At noon, it will rush to a high position again.

Next, the company will announce its development plan and the stock price will rise a lot.

美全股价大涨 一周劲扬逾200%
Chinapress Mon, Nov 16, 2020 09:50am - 1 hour ago


(吉隆坡16日讯)美全（MTRONIC，0043，主板工业股）继上周交易活络股价翻涨183%至17仙闭市后，今日甫开盘续一度涨至18.5仙高点，综合上周涨幅，6个交易日内的增长幅度高达208%。





美全今日开盘股价走高 ，且交投活络，自以17仙平盘开市后，盘中一度再涨8.8%或1.5仙至18.5仙水平，半小时就有逾2亿股易手，为10大热门股之一。

截至上午9时半，该股报17.5仙，扬2.94仙，成交量达2亿354万5700股。

在过去5个交易日内，美全交投亦极为活络，单周成交量超过28亿股。此外，该股上周五(13日)也飚涨了从前周五(6日)闭市水平6仙涨183%至17令吉的水平。

据报备文件，美全在截至今年6月底的次季拥有6820万令吉现金储备金，这或也是另一个吸引投资者投资的原因之一。

在经过上周的涨势之后，美全的市值也在一周内由1亿4326万令吉，迅速膨胀至2亿1178万令吉。

The rise will not stop so quickly, at least it will rise to 0.40-0.50.

Jjkcl： Mesti jatuh kuat ha ha ha！

It will rise again at noon.

Obviously this counter is controlled by big investors.

Obviously this counter is controlled by big investors.

This counter is to sell covid vaccines. Hold it tightly. Don't sell it so quickly, or you will regret it.

The last time I bought kstar at 0.18, when it rose to 0.30, I thought it would not go up again. After selling, it rose to 0.96 every day, wasting money-making opportunities.

Last time HLCAP encountered the same problem, but its stock price rose higher and higher.

Usually when new shareholders join, the stock price will be copied higher.

Is it a proxy vaccine?

Retail investors sell and large investors buy.

The stock price will rise even higher after the rebound.

is officially announced tomorrow that Biden won the general election and this counter will limit up.

民泰近电合作伙伴签署框架协议 在中国开发与商业化li-Key疫苗
TheEdge Thu, Nov 05, 2020 01:45pm - 2 hours ago


（吉隆坡5日讯）民泰近电（Bintai Kinden Corp Bhd）的合作伙伴Generex Biotechnology Corp已签署框架协议，以在中国开发和商业化Ii-Key-SARS-CoV-2冠状病毒疫苗。

民泰近电今日发布文告指出，其合作伙伴已与中国疾病预防控制中心、北京国信海翔股权投资合作伙伴及北京友丰国际咨询有限公司签署协议。

根据框架协议，Generex将获得预付款和后端授权费用。

这些合作伙伴将进行研发，并支付Ii-Key-SARS-CoV-2疫苗商业批准所需的100%资金，包括实验室工作、生产、监管申报和中国监管批准疫苗的临床开发计划。

民泰近电子公司Bintai Healthcare私人有限公司于10月份和Generex及其子公司NuGenerex Immuco-Oncology Inc签署了在大马的新冠疫苗分销和许可协议。

根据协议，Bintai Healthcare被授予在大马、汶莱、缅甸、柬埔寨、东帝汶、印尼、寮国、菲律宾、新加坡、泰国和越南分销、销售和商业化新冠疫苗的独家权利。

民泰近电说：“它还将拥有在纽西兰、澳洲和全球清真市场对该疫苗进行商业开发的优先权。”

截至早盘休市，民泰近电起1仙或1.54%，至66仙，市值为2亿1007万令吉。

According to the agreement, Bintai Healthcare was granted the exclusive rights to distribute, sell and commercialize the new crown vaccine in Malaysia, Brunei, Myanmar, Cambodia, East Timor, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam.

ProXmask™ registered with US FDA https://www.klsescreener.com/v2/news/view/749215/proxmask-registered-with-us-fda
TheEdge Thu, Nov 05, 2020 10:40am - 5 minutes ago



Honsin Apparel Sdn. Bhd., a wholly-owned subsidiary of Prolexus Berhad (Prolexus), is registered with the U.S. Food and Drug Administration (FDA) for face mask for general public / healthcare personnel per Immediately in Effect Guidance (IIE Guidance). The registration is expected to expand ProXmask™ export market horizon to the US market to curb Covid-19 pandemic.

Prolexus, which is already an established international sportswear manufacturer, has aggressively responded to the unprecedented pandemic crisis through the development of ProXmask™ as one of its core products. Prolexus aspires to deliver high quality reusable functional fabric mask to ensure effective protection for everyone against the virus.


Prolexus revealed its cutting edge ProX™ anti-virus technology which inactivates bacteria and viruses, including >99% SARS-CoV-2, the virus responsible for Covid-19. The technology, accompanied with its water repellency and microfiltration properties, enables ProXmask™ to be both protective and preventive, benefiting both self and others in close proximity. The absence of self-disinfection property in conventional disposal masks however, increases the risk of disease spread upon improper handling and disposal.

Moreover, the reusability of ProXmask™ makes it an eco-friendly and cost-effective choice. It stays effective up to 60 wash cycles, making it equivalent to at least 120 disposal masks, assuming a 4 to 6 hours of usage lifespan (as doctors' advise) per disposal mask. Its protective features also exceed the ones in disposal masks, making it a value for money product.


ProXmask™ protective features have passed the test conducted by various international accredited laboratories. Backed by its advanced ProX™ anti-virus technology, Prolexus is set to explore innovative market segments such as personal protective apparels, a new emerging sportswear category. Prolexus marketing is actively working towards serving prospective clients with interest in protective and functional activewears.

Any interested parties, please call 1700-81-8398, email info@proxmask.com or visit www.prolexus.com.my/proxmask

https://www.klsescreener.com/v2/news/view/749215/proxmask-registered-with-us-fda

ProXmask™ registered with US FDA
TheEdge Thu, Nov 05, 2020 10:40am - 5 minutes ago



Honsin Apparel Sdn. Bhd., a wholly-owned subsidiary of Prolexus Berhad (Prolexus), is registered with the U.S. Food and Drug Administration (FDA) for face mask for general public / healthcare personnel per Immediately in Effect Guidance (IIE Guidance). The registration is expected to expand ProXmask™ export market horizon to the US market to curb Covid-19 pandemic.

Prolexus, which is already an established international sportswear manufacturer, has aggressively responded to the unprecedented pandemic crisis through the development of ProXmask™ as one of its core products. Prolexus aspires to deliver high quality reusable functional fabric mask to ensure effective protection for everyone against the virus.


Prolexus revealed its cutting edge ProX™ anti-virus technology which inactivates bacteria and viruses, including >99% SARS-CoV-2, the virus responsible for Covid-19. The technology, accompanied with its water repellency and microfiltration properties, enables ProXmask™ to be both protective and preventive, benefiting both self and others in close proximity. The absence of self-disinfection property in conventional disposal masks however, increases the risk of disease spread upon improper handling and disposal.

Moreover, the reusability of ProXmask™ makes it an eco-friendly and cost-effective choice. It stays effective up to 60 wash cycles, making it equivalent to at least 120 disposal masks, assuming a 4 to 6 hours of usage lifespan (as doctors' advise) per disposal mask. Its protective features also exceed the ones in disposal masks, making it a value for money product.


ProXmask™ protective features have passed the test conducted by various international accredited laboratories. Backed by its advanced ProX™ anti-virus technology, Prolexus is set to explore innovative market segments such as personal protective apparels, a new emerging sportswear category. Prolexus marketing is actively working towards serving prospective clients with interest in protective and functional activewears.

Any interested parties, please call 1700-81-8398, email info@proxmask.com or visit www.prolexus.com.my/proxmask

Today will limit up.

kstar-wa will not fall yet.

Please limit up it tomorrow.

Local investors sell the Chinese boss to buy.

The next trading session will be more exciting.

A profitable company need not worry.

https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=0100

FINANCIAL SUMMARY
SYMBOL & CODE ESCERAM (0100)
CURRENT QUARTER Q1 2021
PAST REPORTS
Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019
CONSOLIDATED INCOME STATEMENT
Individual Period Cumulative Period
31 Aug 2020 31 Aug 2019 31 Aug 2020 31 Aug 2019
RM'000 RM'000 RM'000 RM'000
REVENUE
11,940 KLSE Quarter Report(+36%)
8,753
11,940 KLSE Quarter Report(+36%)
8,753
PROFIT/(LOSS) BEFORE INCOME TAX
3,202 KLSE Quarter Report(+218%)
1,006
3,202 KLSE Quarter Report(+218%)
1,006
NET PROFIT/(LOSS)
3,202 KLSE Quarter Report(+218%)
1,006
3,202 KLSE Quarter Report(+218%)
1,006
BASIC (BASED ON ORDINARY SHARES - SEN)
1.50 KLSE Quarter Report(+200%)
0.50
1.50 KLSE Quarter Report(+200%)
0.50
DIVIDEND PER SHARE (SEN)
1.00 KLSE Quarter Report(+67%)
0.60
1.00 KLSE Quarter Report(+67%)
0.60
NET ASSETS PER SHARE (RM)
0.290 KLSE Quarter Report(+16%)
0.250

Don't forget that the gloves have not yet started production.

https://9shares.my/%e4%b8%9c%e5%8d%97%e9%99%b6%e7%93%b7q1%e5%87%80%e5%88%a9%e6%8c%89%e5%b9%b4%e9%a3%8a218-%e5%87%80%e8%b5%9a320%e4%b8%87%e4%bb%a4%e5%90%89%e6%b4%be%e6%81%af%e6%af%8f%e8%82%a11%e4%bb%99/?fbclid=IwAR1dY2Pjf1y7C9oy7PH0Jm-7urY8kbgws70jWV7HQG2wd_yds_6mm3NNqEM

东南陶瓷Q1净利按季飊1336%
净赚320万令吉派息每股1仙
15/10/2020
十四日完成红股除权的东南陶瓷（ESCERAM 0100）公布截至八月卅一日第一季（Q1）业绩，净利比上一季增长1336%，净赚320万令吉，上一季度该公司蒙受25万9000令吉亏损。

同比去年相同季度，净利增长36.4%，去年Q1净赚100万6000令吉。

Q1营业额按年增长36.4%，由去年875万令吉增至1994万令吉；每股盈利（EPS）为1.50仙，同比0.49仙。

东南陶瓷建议派发每股1仙股息，以回馈股东。

东南陶瓷股价今日收於90仙，其红股除权後的参阅价格是52.6仙，该股昨日一度涨停板，今早开市後一度冲破RM1.00，午後股价回顺。

东南陶瓷是在十月初宣布以1送1股派发红股，并附送1张免费凭单；其红股及凭单会迟至十月廿六日才进入股东CDS户口。

东南陶瓷是一家专门生产手套陶制模具工厂，手套需求因为新冠肺炎瘟疫大增，手套厂纷纷投入扩厂增产行列，间接刺激东南陶瓷的生意量。

该公司表示，手套需求提高，管理层将采取更精明及严谨现金管控，确保集团交出更好业绩。

I think this counter will go to RM4.

EPF continues to buy.

中國報北馬人
21分钟 ·
该公司已进行消毒，所有密切接触者的拭子检测也已完成。
http://penang.chinapress.com.my/?p=1495286
⬇看过来⬇
➡登广告/订阅《中国报》请联络：04-2627395… 展开
◤北马疫急◢ Plexus 2员工确诊 密切接触者皆呈阴性|中國報
PENANG.CHINAPRESS.COM.MY | 作者：CHINA PRESS (中國報)
◤北马疫急◢ Plexus 2员工确诊 密切接触者皆呈阴性|中國報
（槟城15日讯）Plexus Manufacturing有限公司指出，该公司槟州厂房有两名

http://penang.chinapress.com.my/?p=1495286

Still dreaming and waiting for RM180.

Continue collection.

It will rise now until the dividend day.

When will Dividend RM180 come.Ha Ha Ha

DPIH Dividend 0.2000 stock price reached 0.30 and Karyon Dividend was 0.7000.

Karyon Industries Bhd (KARY)https://cn.investing.com/equities/karyon-industries-bhd-technical

马来西亚吉隆坡
创建提醒
添加至投资组合
0.240 +0.025 +11.63%
09:26:00 - 延迟数据. MYR 货币 ( 免责声明 )
类型:

股票
市场:

马来西亚
ISIN:

MYQ0054OO005
S/N:

0054
量: 10,494,200 卖价/买价: 0.235 / 0.240 当日幅度: 0.220 - 0.245

Karyon Industries 0.240 +0.025 +11.63%
总况 图表 财务状况 技术 论坛
技术分析K线型态一致预期
KARY技术分析
5 分钟
15 分钟
30 分钟
每小时
5 小时
每日
每周
每月
总结:
强力买入
移动平均指数:买入买入 (12)卖出 (0)
技术指标:强力买入买入 (7)卖出 (1)

MELAKA (Sept 7): The proposed Malaysia Tourism City (MTC) project which would feature the world’s first Hasbro water theme park in Kuala Linggi here is waiting for approval from the Economic Planning Unit (EPU).

Tourism, Arts and Culture Minister Datuk Seri Nancy Shukri said the project worth RM120 million should be scrutinised properly, before it is finalised.

“The ministry has presented the project’s proposal to the EPU and they have already visited the site. That means there is a potential that the project will be developed there.

“We hope the EPU will approve the project soon,” she told reporters after paying a courtesy call on the Yang Dipertua Negeri Tun Mohd Ali Rustam at his office in Ayer Keroh here, today.

Also present was the ministry’s secretary-general Datuk Dr Noor Zari Hamat.

The MTC project to be developed by Meridian Bhd comprises four main branches, namely mass tourism, health tourism, education tourism and ecotourism on a 251-hectare land.

Among the components of the project is the Hasbro Theme Park, in which the international toy brand will have about 1,000 intellectual properties on-site such as Nerf, My Little Pony, Mr Potato Head, Play-Doh, Battleship, Monopoly, Elefun & Friend, as well as Mousetrap.

The project is expected to generate RM5 billion additional income to the country’s tourism sector.

Earlier, Nancy said various issues pertaining to tourism, culture, arts and heritage were discussed during the courtesy call.

“The ministry welcomes several views shared by Tun Mohd Ali in order to further develop the tourism sector in Melaka and they will be brought up at the ministerial level,” she said.

You said it yourself.

Now the most promising one is kstar.

When it rebounded, everyone rushed in again to buy.

Who knows what news it has.

It seems that it can rise a lot.

Will it rise again tomorrow.

Rush up before the market closes.

The price will slowly increase.

方案工程上挑80仙/敏源
Nanyang Wed, Sep 23, 2020 12:02am - 14 hours ago



马股周二在金融股领涨下成功重返1500线上，富时隆综指的交投走势反弹了。

富时隆综指于9月22日闭市时以1505.78点报收，按日涨6.35或0.42%。整日交投波幅介于16.97（1494.93-1511.90）点间。

上升股项为431只，而下跌股项为600只。

方案工程（SOLUTN，0093，创业板）于9月22日闭市时收69仙，按日涨5仙或7.81%。

方案工程的30分钟图表走势，于9月22日的交投走势沿着它的上升趋势线（B1:B2）上爬升。

它的30分钟平滑异同移动均线指标（MACD），于9月22日的交投走势处于一个调整的格局。

它处于“0”支撑线上波动，方案工程的后市交投走势，或会出现一段短线回试它的下限支撑线的支撑（B1:B2）。

方案工程的日线图表走势于回试后，或会显现一段反弹走势，它或会挑战70-80仙的阻力水平。

When the news fades, it will definitely rush upwards.

When the news fades, it will definitely rush upwards.